Homestead Advisers Corp Amgen Inc Transaction History

Homestead Advisers Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $26.9 Million - $30.8 Million	-135,500 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $106,135 - $124,350	500 Added 0.37%	135,500 $28.8 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $490,518 - $544,194	-2,100 Reduced 1.53%	135,000 $32.9 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $1.6 Million - $1.86 Million	-7,200 Reduced 4.99%	137,100 $34.1 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $757,330 - $901,845	-3,500 Reduced 2.37%	144,300 $33.2 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $34.7 Million - $38.6 Million	147,800 New	147,800 $37.6 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.